Evidence map›Paper›PMID 36688938›Full record

Article21st century pathology2022

A Double Jeopardy: Loss of FMRP Results in DSB and Down-regulated DNA Repair.

Arijita Chakraborty, Andre Grageda, Vladimir A Kuznetsov, Wenyi Feng

Open access · greenAbstract read
In one paragraph

Article in 21st century pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Arijita ChakrabortyDepartment of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, New York, USA.ORCID 0000-0002-4616-4399
Andre GragedaDepartment of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, New York, USA.ORCID 0000-0001-7532-1499
Vladimir A KuznetsovDepartment of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, New York, USA.ORCID 0000-0003-3405-0762
Wenyi FengDepartment of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, New York, USA.ORCID 0000-0002-6123-7998
SUNY Upstate Medical University · USXperi (United States) · US

Funding

Understanding the Genome Maintenance Function of the Fragile X Protein (FMRP)R21MH130812 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI FENG, WENYI · 2022 to 2023
$448k
NIMH NIH HHS R21 MH130812
6 · The paper itself

Abstract

Our understanding of the molecular functions of the nucleocytoplasmic FMRP protein, which, if absent or dysfunctional, causes the fragile X syndrome (FXS), largely revolves around its involvement in protein translation regulation in the cytoplasm. Recent studies have begun honing in on the nuclear and genomic functions of FMRP. We have shown that during DNA replication stress, cells derived from FXS patients sustain increased level of R-loop formation and DNA double strand breaks. Here, we describe a transcriptomic analysis of these cells in order to identify those genes most impacted by the loss of FMRP with and without replication stress. We show that FMRP loss causes transcriptomic changes previously reported in untreated conditions. Importantly, we also show that replication stress, in addition to causing excess of DSB, results in down-regulation of transcription in virtually all DNA repair pathways. This finding suggests that despite normal DNA damage response, FXS patient-derived cells experience R-loop-induced DNA breakage as well as impaired DNA repair functions, effectively a double jeopardy. We suggest that it is imperative to deepen the understanding of the nuclear functions, particularly a genome protective function, of FMRP, which will lead to discoveries of novel therapeutic interventions for the FXS.

Indexed as

DNA double strand breaks (DSBs)DNA repairFMR1FMRPfragile X Syndrome (FXS)Genome instabilityR-loop

Identifiers

PMID36688938
PMCPMC9850805
OpenAlexW4317780769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.